Oleuropein Aglycone Protects Transgenic C. elegans Strains Expressing Aβ42 by Reducing Plaque Load and Motor Deficit

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Diomede, Luisa ^a   Rigacci, Stefania ^b,c   Romeo, Margherita ^a   Stefani, Massimo ^b,c,d   Salmona, Mario ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Research Center on the Molecular Basis of Neurodegeneration   (Italy)

^d NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; AMYLIN; AMYLOID BETA PROTEIN; OLEUROPEIN; OLIGOMER; OLIVE OIL;

ANTIOXIDANT ACTIVITY; ARTICLE; CAENORHABDITIS ELEGANS; CYTOPLASM; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MOTOR DYSFUNCTION; MUSCLE CELL; NONHUMAN; PROTEIN AGGREGATION; PROTEIN INDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CAENORHABDITIS; DISEASE MODELS, ANIMAL; HUMANS; PEPTIDE FRAGMENTS; PYRANS; VASODILATOR AGENTS;

EID: 84874778760     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058893     Document Type: Article

References (53)

1. Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, et al. (2002) The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu Rev Public Health 23: 213-231.
2. Selkoe DJ, (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741-766.
3. Selkoe DJ, (2002) Alzheimer's disease is a synaptic failure. Science 298: 789-791.
4. Ling Y, Morgan K, Kalsheker N, (2003) Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. Int J Biochem Cell Biol 35: 1505-1535.
5. Selkoe DJ, (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487-498.
6. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, et al. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539.
7. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, et al. (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8: 79-84.
8. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, et al. (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci 4: 887-893.
9. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, et al. (2003) Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A 100: 10417-10422.
10. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, et al. (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440: 352-357.
11. LaFerla FM, Green KN, Oddo S, (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8: 499-509.
12. Engel WK, Askanas V, (2006) Inclusion-body myositis: clinical, diagnostic, and pathologic aspects. Neurology 66: S20-29.
13. Askanas V, Engel WK, (2008) Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains. Acta Neuropathol 116: 583-595.
14. D'Agostino C, Nogalska A, Cacciottolo M, Engel WK, Askanas V, (2011) Abnormalities of NBR1, a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis. Acta Neuropathol 122: 627-636.
15. Kitazawa M, Green KN, Caccamo A, LaFerla FM, (2006) Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice. Am J Pathol 168: 1986-1997.
16. Beauchamp GK, Keast RS, Morel D, Lin J, Pika J, et al. (2005) Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature 437: 45-46.
17. Alavez S, Vantipalli MC, Zucker DJ, Klang IM, Lithgow GJ, (2011) Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature 472: 226-229.
18. Scarmeas N, Luchsinger JA, Stern Y, Gu Y, He J, et al. (2011) Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol 69: 257-268.
19. Sofi F, Abbate R, Gensini GF, Casini A, (2010) Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 92: 1189-1196.
20. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA, (2006) Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 59: 912-921.
21. Feart C, Samieri C, Barberger-Gateau P, (2010) Mediterranean diet and cognitive function in older adults. Curr Opin Clin Nutr Metab Care 13: 14-18.
22. Farr SA, Price TO, Dominguez LJ, Motisi A, Saiano F, et al. (2012) Extra virgin olive oil improves learning and memory in SAMP8 mice. J Alzheimers Dis 28: 81-92.
23. Papandreou MA, Dimakopoulou A, Linardaki ZI, Cordopatis P, Klimis-Zacas D, et al. (2009) Effect of a polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity. Behav Brain Res 198: 352-358.
24. Ladiwala AR, Dordick JS, Tessier PM, (2011) Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways. J Biol Chem 286: 3209-3218.
25. Zhu JT, Choi RC, Xie HQ, Zheng KY, Guo AJ, et al. (2009) Hibifolin, a flavonol glycoside, prevents beta-amyloid-induced neurotoxicity in cultured cortical neurons. Neurosci Lett 461: 172-176.
26. Feng Y, Yang SG, Du XT, Zhang X, Sun XX, et al. (2009) Ellagic acid promotes Abeta42 fibrillization and inhibits Abeta42-induced neurotoxicity. Biochem Biophys Res Commun 390: 1250-1254.
27. Feng Y, Wang XP, Yang SG, Wang YJ, Zhang X, et al. (2009) Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Neurotoxicology 30: 986-995.
28. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, et al. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15: 558-566.
29. Rigacci S, Guidotti V, Bucciantini M, Nichino D, Relini A, et al. (2011) Abeta(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. Curr Alzheimer Res 8: 841-852.
30. Daccache A, Lion C, Sibille N, Gerard M, Slomianny C, et al. (2011) Oleuropein and derivatives from olives as Tau aggregation inhibitors. Neurochem Int 58: 700-707.
31. Mori T, Rezai-Zadeh K, Koyama N, Arendash GW, Yamaguchi H, et al. (2012) Tannic acid is a natural beta-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. J Biol Chem 287: 6912-6927.
32. Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, et al. (2009) Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem Int 54: 111-118.
33. Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, et al. (2008) Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res 1214: 177-187.
34. Berr C, Portet F, Carriere I, Akbaraly TN, Feart C, et al. (2009) Olive oil and cognition: results from the three-city study. Dement Geriatr Cogn Disord 28: 357-364.
35. Bazoti FN, Bergquist J, Markides K, Tsarbopoulos A, (2008) Localization of the noncovalent binding site between amyloid-beta-peptide and oleuropein using electrospray ionization FT-ICR mass spectrometry. J Am Soc Mass Spectrom 19: 1078-1085.
36. Pitt J, Roth W, Lacor P, Smith AB 3rd, Blankenship M, et al (2009) Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol Appl Pharmacol 240: 189-197.
37. Soler-Rivas C, Espín JC, Wichers H, (2000) Oleuropein and related compounds. Journal of the Science of Food and Agriculture 80: 1013-1023.
38. Bazoti FN, Bergquist J, Markides KE, Tsarbopoulos A, (2006) Noncovalent interaction between amyloid-beta-peptide (1-40) and oleuropein studied by electrospray ionization mass spectrometry. J Am Soc Mass Spectrom 17: 568-575.
39. Rigacci S, Guidotti V, Bucciantini M, Parri M, Nediani C, et al. (2010) Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. J Nutr Biochem 21: 726-735.
40. Link CD, (1995) Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A 92: 9368-9372.
41. Link CD, (2005) Invertebrate models of Alzheimer's disease. Genes Brain Behav 4: 147-156.
42. Wu Y, Wu Z, Butko P, Christen Y, Lambert MP, et al. (2006) Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci 26: 13102-13113.
43. McColl G, Roberts BR, Gunn AP, Perez KA, Tew DJ, et al. (2009) The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42. J Biol Chem 284: 22697-22702.
44. Luo Y, (2006) Alzheimer's disease, the nematode Caenorhabditis elegans, and ginkgo biloba leaf extract. Life Sci 78: 2066-2072.
45. Gutierrez-Zepeda A, Santell R, Wu Z, Brown M, Wu Y, et al. (2005) Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans. BMC Neurosci 6: 54.
46. Morita M, Osoda K, Yamazaki M, Shirai F, Matsuoka N, et al. (2009) Effects of non-steroidal anti-inflammatory drugs on Abeta deposition in Abeta(1-42) transgenic C. elegans. Brain Res 1295: 186-191.
47. Diomede L, Cassata G, Fiordaliso F, Salio M, Ami D, et al. (2010) Tetracycline and its analogues protect Caenorhabditis elegans from beta amyloid-induced toxicity by targeting oligomers. Neurobiol Dis 40: 424-431.
48. Wu Z, Smith JV, Paramasivam V, Butko P, Khan I, et al. (2002) Ginkgo biloba extract EGb 761 increases stress resistance and extends life span of Caenorhabditis elegans. Cell Mol Biol (Noisy-le-grand) 48: 725-731.
49. Link CD, Johnson CJ, Fonte V, Paupard M, Hall DH, et al. (2001) Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiol Aging 22: 217-226.
50. Omar SH, (2010) Oleuropein in olive and its pharmacological effects. Sci Pharm 78: 133-154.
51. Stefani M, (2010) Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity. FEBS J 277: 4602-4613.
52. Caruana M, Hogen T, Levin J, Hillmer A, Giese A, et al. (2011) Inhibition and disaggregation of alpha-synuclein oligomers by natural polyphenolic compounds. FEBS Lett 585: 1113-1120.
53. Bastianetto S, Krantic S, Quirion R, (2008) Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease. Mini Rev Med Chem 8: 429-435.